- This meeting has passed.
Frontline Advancements: Clinical Data Overview of Echelon-1 and Echelon-2
May 16, 2019 @ 6:30 pm - 9:00 pm
Join Caroline Behler, MD, as she reviews data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphomas (PTCL).
“My ANCO membership and board involvement have been invaluable in enabling me to connect with colleagues beyond my sphere at Stanford. I have had the opportunity to interact with physicians at UCSF, UC Davis, the Permanente Medical Group and with numerous private practices. My participation in the enlightening Multidisciplinary Management of Cancers Meeting has enriched my career and connections with oncologists in Northern California.”
A. Dimitrios Colevas, M.D.
Professor of Medicine, Stanford University